Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden
· Delayed Price · Currency is SEK 9.14
-0.29 (-3.08%)
May 9, 2025, 5:29 PM CET
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 961.20 million as of May 13, 2025. Its market cap has decreased by -2.43% in one year.
Market Cap
961.20M
Enterprise Value
857.45M
Revenue
182.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.14
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 961.20M, an increase of 625.35%. That is a compound annual growth rate of 17.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 102.97B |
| Sectra AB | 59.23B |
| Getinge AB | 50.70B |
| Camurus AB | 39.14B |
| Medicover AB | 36.18B |
| AddLife AB | 22.95B |
| Vitrolife AB | 21.42B |
| Vimian Group AB | 20.64B |